Winton Group’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-20,824
| Closed | -$151K | – | 871 |
|
|
2023
Q1 | $151K | Sell |
20,824
-306
| -1% | -$2.22K | 0.01% | 916 |
|
|
2022
Q4 | $187K | Buy |
21,130
+1,201
| +6% | +$10.7K | 0.01% | 873 |
|
|
2022
Q3 | $244K | Sell |
19,929
-2,473
| -11% | -$30.3K | 0.02% | 848 |
|
|
2022
Q2 | $265K | Buy |
22,402
+4,766
| +27% | +$56.4K | 0.01% | 831 |
|
|
2022
Q1 | $335K | Buy |
17,636
+3,307
| +23% | +$62.8K | 0.02% | 790 |
|
|
2021
Q4 | $380K | Buy |
+14,329
| New | +$380K | 0.02% | 757 |
|
|
2021
Q1 | – | Sell |
-7,723
| Closed | -$541K | – | 1389 |
|
|
2020
Q4 | $541K | Sell |
7,723
-37,661
| -83% | -$2.64M | 0.04% | 754 |
|
|
2020
Q3 | $1.27M | Buy |
45,384
+33,962
| +297% | +$953K | 0.04% | 708 |
|
|
2020
Q2 | $338K | Sell |
11,422
-14,163
| -55% | -$419K | 0.01% | 1257 |
|
|
2020
Q1 | $507K | Buy |
+25,585
| New | +$507K | 0.01% | 1027 |
|